CMS Proposed Rule Would Extend Immunosuppressive Drug Coverage for Individuals with a Kidney Transplant

On April 22, 2022, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule (CMS-4199-P) to implement sections of the Consolidated Appropriations Act, 2021 (CAA) that would simplify Medicare enrollment rules and extend coverage of immunosuppressive drugs for certain beneficiaries. Specifically, Section 402 of the CAA extends immunosuppressive drug coverage under Part B for certain individuals whose Medicare entitlement based on end-stage renal disease would otherwise end 36 months after the month in which they received a successful kidney transplant provided they do not have certain other health coverage. Comments on the proposed rule are due to CMS by June 27, 2022.